Bibliographic Info
GuidelineConsolidated guidelines on general HIV care and the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year of Publication2013
Issuing InstitutionWHO
Recommendation
Status
Maintained
Recommended in favor
Strong
Certainty of evidence
Low
After failure of a first-line regimen of abacavir (ABC) or tenofovir disoproxil fumarate (TDF) + lamivudine (3TC) or emtricitabine (FTC), the preferred nucleoside reverse transcriptase inhibitor (NRTI) backbone option for second-line ART is zidovudine (AZT) + 3TC
Also Featured In
This recommendation also appears in the following guidelines:
Guideline
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach
Year2016
InstitutionWHO